Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA
Holding TSE:MDNA?
Track your performance easily

Medicenna Therapeutics Corp (MDNA) Financial Statements

181 Followers

Medicenna Therapeutics Corp Financial Overview

Medicenna Therapeutics Corp's market cap is currently ―. The company's EPS TTM is C$-0.374; its P/E ratio is -5.94; Medicenna Therapeutics Corp is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -3.64MC$ -13.90MC$ -4.98MC$ -3.72MC$ -5.36M
EBITDAC$ -3.63MC$ -13.90MC$ -4.98MC$ -3.72MC$ -5.36M
Net Income Common StockholdersC$ -3.64MC$ -13.90MC$ -4.98MC$ -3.72MC$ -5.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 35.63MC$ 16.98MC$ 21.76MC$ 25.69MC$ 29.61M
Total AssetsC$ 38.02MC$ 19.13MC$ 23.27MC$ 27.74MC$ 31.55M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -35.63MC$ -16.98MC$ -21.76MC$ -25.69MC$ -29.61M
Total LiabilitiesC$ 15.14MC$ 13.94MC$ 4.64MC$ 4.31MC$ 4.65M
Stockholders EquityC$ 22.88MC$ 5.19MC$ 18.63MC$ 23.44MC$ 26.90M
Cash Flow-
Free Cash FlowC$ -2.36MC$ -4.84MC$ -4.03MC$ -3.92MC$ -3.47M
Operating Cash FlowC$ -2.33MC$ -4.84MC$ -4.03MC$ -3.92MC$ -3.47M
Investing Cash FlowC$ -31.00K----
Financing Cash FlowC$ 20.90MC$ -3.00KC$ 3.00K--
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Medicenna Therapeutics Corp Debt to Assets

Medicenna Therapeutics Corp Cash Flow

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis